Bibliografia

1. Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84(3):351–8.
2. Yelin E. The economics of osteoarthritis. In: Brandt KD, Doherty M, Lohmander LS, Eds. Osteoarthritis. New York: Oxford University Press. 1998;23-30.
3. Meenan RF, Callahan LF, Helmick CG. The National Arthritis Action Plan: a public health strategy for a looming epidemic Editorial. Arthritis Care Res. 1999;12(2):79-81.
4. Leardini G, Salaffi F, Montanelli R, et al. A multicentric study of annual costs of knee osteoarthritis in Italy. Arthritis Rheum 2001;44:S313.
5. Davis MA. Epidemiology of osteoarthritis. Clin Geriatr Med. 1988;4(2):24155.
6. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum 1998;41(8):1343-55.
7. Bellamy N, Watson Buchanan W, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or the knee. J Rheumatol 1988;15(12):1833-40.
8. Bellamy N, Buchanan WW, Goldmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically-important patient relevant outcomes following total hip or knee arthro plasty in osteoarthritis. J Orthop Rheumatol 1988;1:95-108.
9. Salaffi F, Leardini G, Canesi B, et al. Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2003;11(8):551-60.
10. Salaffi F, Blasetti P, Del Medico P, et al. Affidabilità e validità della versione italiana del WOMAC nella valutazione della gonartrosi sintomatica. Reumatismo. 2000;52(Suppl 2):602.